Form 4 · Filed Jun 15, 2026, 10:37 PM UTC
LYEL/Lyell Immunopharma, Inc.
Seely Lynn — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 11, 2026 | S | sell | 388 | $19 | $7,337 | 73,878 |
Source: SEC EDGAR raw filing ↗ · Accession 0001327111-26-000003